BPC-157 & TB-500 Dosage Guide
Complete guide to BPC-157 & TB-500 dosing protocols, administration methods, and safety considerations for research purposes.
Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.
Recommended Dosage
Typical research protocols: BPC-157 at 250-500mcg daily combined with TB-500 at 2-2.5mg twice weekly during loading phase, then 2mg every 2 weeks for maintenance.
Administration Method
Both peptides administered via subcutaneous injection. Some protocols suggest injecting near injury sites for localized effects. Can be injected separately or as a pre-mixed blend.
Side Effects to Monitor
Generally well-tolerated. May include mild nausea, temporary fatigue, headache, or localized irritation at injection sites.
Safety Considerations & Risks
Limited human clinical trial data for the combination. Theoretical concerns about promoting growth of existing cancers due to angiogenic properties. Not FDA approved for human use.